ISPC vs ROP · rev $9.3M vs P/E 41, rev $1.88B
iSpecimen Inc (ISPC) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
ISPC currently screens at market cap $4.4M. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the ISPC and ROP stock pages for the full models.
Not investment advice.